← Leaderboards
To-Ha Thai
Beth Israel Deaconess Medical Center
$1,330,153
Attributed
$1,330,153
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $435K · FY2012–20$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,330,153 · 3
By mechanism
R21$895,153 · 2
R56$435,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Corey S Cutler$6,266,747
- Iannis Elias Adamopoulos$7,190,922
- Fredric E. Wondisford$29,129,494
- Richard A. Hodin$11,784,355
- Roya Khosravi-Far$10,044,273
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelHistonesIn VivoCellsChromatin RemodelingReaderMhc Class I GenesBindingTumorProductionCd8-Positive T-LymphocytesMicrornasModificationLinkCd4 Positive T LymphocytesMalignant NeoplasmsComplexEpigenetic ProcessCd8b1 GeneGeneticInnovationChromatin StructureGene ExpressionMediating
Grant awards (5)
Potential role of heterochromatin protein 1γ in the control of FOXP3 stability and expression in induced CD4+ regulatory T cells$262,500
R21 · FY2020 · AI · contact PI
Potential role of heterochromatin protein 1γ in the control of FOXP3 stability and expression in induced CD4+ regulatory T cells$218,750
R21 · FY2019 · AI · contact PI
Cbx-3/HP-1gamma deficiency confers anti-tumor immunity$225,765
R21 · FY2017 · CA · contact PI
Cbx-3/HP-1gamma deficiency confers anti-tumor immunity$188,138
R21 · FY2016 · CA · contact PI
Regulation of chromatin modifications by miRNAs to control cytokine expression$435,000
R56 · FY2012 · AI · contact PI